Acute changes in serum thyrotrophin in treated Addison's disease

Area of Science:

• Endocrinology
• Hormone Replacement Therapy
• Thyroid Function Testing

Background:

• Addison's disease requires lifelong glucocorticoid and often mineralocorticoid replacement therapy.
• Thyroid-stimulating hormone (TSH) levels are a key indicator of thyroid function and can be influenced by various factors.
• The impact of acute steroid administration on TSH levels in Addison's disease patients is not well-established.

Purpose of the Study:

• To investigate the acute effect of morning steroid replacement therapy on serum TSH levels in patients with Addison's disease.
• To assess the influence of hydrocortisone and dexamethasone on TSH, ACTH, and other pituitary hormone levels.
• To determine the impact of medication timing on TSH measurement accuracy in treated Addison's disease.

Main Methods:

• Measurement of serum cortisol, plasma ACTH, serum TSH, free T4, free T3, PRL, LH, and FSH.
• Serial blood sampling hourly for 4 hours post-morning steroid (hydrocortisone) administration.
• Comparison with measurements obtained when morning steroid dose was withheld and after dexamethasone administration in some patients.

Main Results:

• Serum TSH levels significantly decreased in all five patients within 4 hours after hydrocortisone administration.
• This TSH reduction was not observed when the morning steroid dose was withheld.
• Dexamethasone also induced similar TSH changes in two patients; LH, FSH, and PRL levels showed no consistent changes.

Conclusions:

• Acute administration of hydrocortisone, a common steroid replacement therapy, transiently suppresses TSH levels in Addison's disease patients.
• The timing of blood sample collection relative to steroid medication intake is crucial for accurate TSH interpretation in this population.
• Clinicians should consider the influence of recent steroid therapy when evaluating TSH results in patients with treated Addison's disease.